These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4824)

  • 1. Intensive design in medical research.
    Chassan JB
    Pharmacol Ther B; 1975; 1(1):139-48. PubMed ID: 4824
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of anxiety in outpatient trials: detection of bias in patient and doctor ratings.
    Fisher S
    Psychopharmacol Bull; 1976 Apr; 12(2):17-8. PubMed ID: 3818
    [No Abstract]   [Full Text] [Related]  

  • 3. A multiclinic double-blind trial of the anxiolytic properties of lorazepam in psychiatric outpatient practice [proceedings].
    Lipman R; Vanov SK; Richards DJ
    Psychopharmacol Bull; 1977 Apr; 13(2):17-9. PubMed ID: 16308
    [No Abstract]   [Full Text] [Related]  

  • 4. Pilot open-label study on U-31,889 in anxious in-patients.
    Fabre LF; Harris RT
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):1010-3. PubMed ID: 4154181
    [No Abstract]   [Full Text] [Related]  

  • 5. Brief treatment of anxious patients with halazepam in high doses [proceedings].
    Kellner R; Bruzzese D; Winslow WW
    Psychopharmacol Bull; 1977 Apr; 13(2):21-2. PubMed ID: 16309
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical study of clobazam in alcohol detoxification [proceedings].
    Méry C; Martin JC
    Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):133S. PubMed ID: 35195
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled clinical and quantitative EEG studies of triflubazam (ORF 8063) in patients with anxiety syndrome.
    Itil TM; Akpinar S; Fink M; Polvan N; Huque M; Sungurbey K
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):307-15. PubMed ID: 5248
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical response to a potential non-sedative anxiolytic.
    Collins P; Sakalis G; Minn FL
    Curr Ther Res Clin Exp; 1976 May; 19(5):512-5. PubMed ID: 7434
    [No Abstract]   [Full Text] [Related]  

  • 9. Benzodiazepines and neurotic anxiety. Critique.
    Solomon K
    N Y State J Med; 1976 Dec; 76(13):2156-64. PubMed ID: 11427
    [No Abstract]   [Full Text] [Related]  

  • 10. Validation of a physician rating scale for investigation of antianxiety effects of drugs [proceedings].
    Free SM; Overall JE
    Psychopharmacol Bull; 1977 Apr; 13(2):8-11. PubMed ID: 16312
    [No Abstract]   [Full Text] [Related]  

  • 11. Intensive design in evaluating anxiolytic agents.
    Uhlenhuth EH; Turner DA; Purchatzke G; Gift T; Chassan J
    Psychopharmacology (Berl); 1977 Mar; 52(1):79-85. PubMed ID: 15297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lorazepam in the management of anxiety associated with chronic gastrointestinal disease: a double-blind study.
    Kasich AM
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):292-306. PubMed ID: 5247
    [No Abstract]   [Full Text] [Related]  

  • 13. Multicenter trials and complementary studies of cloxazolam, a new anxiolytic drug.
    Fischer-Cornelssen KA
    Arzneimittelforschung; 1981; 31(10):1757-65. PubMed ID: 6119092
    [No Abstract]   [Full Text] [Related]  

  • 14. Clorazepate dipotassium (Tranxene): a controlled evaluation in alcoholic patients after withdrawal.
    Mielke DH; Gallant DM; McFarlain RA
    Curr Ther Res Clin Exp; 1976 May; 19(5):506-11. PubMed ID: 7433
    [No Abstract]   [Full Text] [Related]  

  • 15. A study in the management of anxiety with lorazepam.
    Ellison RJ; Cancellaro LA
    J Clin Pharmacol; 1978 Apr; 18(4):210-9. PubMed ID: 24646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients.
    Davison K; Farquharson RG; Khan MC; Majid A
    Br J Clin Pharmacol; 1985; 19 Suppl 1(Suppl 1):37S-43S. PubMed ID: 2859877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R; Kahn RJ; McNair DM; Frankenthaler LM
    Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609
    [No Abstract]   [Full Text] [Related]  

  • 18. A brief anxiety rating scale in evaluating anxiolytics.
    Wang RI; Wiesen RL; Treul S; Stockdale S
    J Clin Pharmacol; 1976; 16(2-3):99-105. PubMed ID: 3521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of one-day treatment of anxiety with high doses of halazepam.
    Kellner R; Bruzzese D; Winslow WW; Rada RT; Wall FJ
    J Clin Pharmacol; 1978 Apr; 18(4):203-9. PubMed ID: 24645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot investigation of clinical effects of PM-33, a new anti-anxiety agent.
    Abuzzahab FS; Kulkarni AS
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1181-6. PubMed ID: 4154180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.